How We Do It: Administration Guide for Intralesional Immunotherapy With Talimogene Laherparepvec (T-VEC) for Advanced Melanoma

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Dermatologic surgery 2020-11, Vol.46 (11), p.1455-1457
Hauptverfasser:	Queen, Dawn, Samie, Faramarz H., Zeitouni, Nathalie C.
Format:	Artikel
Sprache:	eng
Schlagworte:	Biological Products - administration & dosage Biological Products - adverse effects Dermatology Dose-Response Relationship, Drug Drug Administration Schedule Herpesvirus 1, Human Humans Injections, Intralesional - instrumentation Injections, Intralesional - standards Life Sciences & Biomedicine Melanoma - diagnosis Melanoma - pathology Melanoma - therapy Neoplasm Staging - methods Oncolytic Virotherapy - adverse effects Oncolytic Virotherapy - instrumentation Oncolytic Virotherapy - methods Oncolytic Virotherapy - standards Patient Selection Practice Guidelines as Topic Science & Technology Skin - diagnostic imaging Skin - pathology Skin Neoplasms - diagnosis Skin Neoplasms - pathology Skin Neoplasms - therapy Surgery Ultrasonography, Interventional
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!